AI-Driven Biomarker Discovery for Targeted Therapies
The Role of AI in Drug Discovery for Rare Diseases
AI holds immense promise for drug discovery for rare diseases, a segment that has historically been neglected due to high R&D costs and a small patient population. The potential of AI in this area is a key opportunity in the Artificial Intelligence in Drug Discovery Market, as detailed in reports like the one on the Artificial Intelligence in Drug Discovery Market. By using AI to analyze genetic data and identify new targets, researchers can more efficiently develop treatments for these conditions. Furthermore, AI-powered drug repurposing is a particularly attractive strategy for rare diseases, as it can accelerate the development process significantly. This article could lead a discussion on the ethical responsibility of technology to address these underserved patient populations.